Alert

Recommended Alerts

Sign Up For Alerts

DEA Announces Proposed Expansion of Controlled Substance Monitoring Requirements

On November 2, 2020, the Drug Enforcement Administration (“DEA”) issued a notice of proposed rulemaking expanding the obligations of DEA registrants to monitor and report suspicious orders for controlled substances (the “Proposal”). The Proposal sets forth a two-option framework for reviewing and reporting suspicious orders, adds new reporting and recordkeeping requirements, and expands the scope of suspicious order monitoring obligations to cover certain hospitals, practitioners and other dispensers. Notably, the Proposal asserts that those hospitals, practitioners and dispensers should already be in compliance with the purported requirements.

Read More

Delaware Supreme Court Changes Law on Burden Shifting in Conflict of Interest Cases and Upholds Huge Damages and Attorney Fee Award

Practices: Life Sciences, Private Equity, Mergers & Acquisitions, Life Sciences Mergers & Acquisitions, Securities & Public Companies

Printer-Friendly Version

Cookie Settings